Leerink Partners Starts Horizon Pharma (HZNP) at Outperform
Tweet Send to a Friend
Leerink Partners initiates coverage on Horizon Pharma (NASDAQ: HZNP) with a Outperform rating and a price target of $37.00.Analyst Jason ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE